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Background: The recent national study, COBIS (Coronary Bifurcation Stenting) I registry, has provided a wealth of information for the treatment of 
bifurcation lesions. The COBIS II study was performed to investigate clinical results of adverse outcomes for left main and non-left main bifurcation 
lesions and effectiveness of newly-introduced drug-eluting stents.
Methods: Consecutive patients who received percutaneous coronary intervention (PCI) for bifurcation lesions were enrolled from 18 centers in 
Korea between January 2003 and January 2010. Inclusion criteria: 1) coronary bifurcation lesions treated solely with drug-eluting stent and 2) a 
main vessel diameter of ≥2.5 mm and side branch diameter of ≥2.3 mm. The exclusion criteria were: 1) cardiogenic shock and 2) cardiopulmonary 
resuscitation before index procedure. Primary outcome was target lesion failure (TLF) including cardiac death, myocardial infarction, and target 
lesion revascularization.
Results: We evaluated 4,511 patients (male: 69.2% and age: 64.5 ± 10.3 years) with bifurcation lesions with a median follow-up duration of 35.2 
months. Left anterior descending artery (59.3%) was the most frequent index-lesion location, followed by left main coronary artery (18.4%), left 
circumflex artery (15.6%), and right coronary artery (6.6%). IVUS-guided PCI was performed in 31.5%. Two-stent technique was used in 15.6%. Among 
the two-stent group, crush technique was used most frequently (39.7%) followed by T-stenting (34.9%). Sirolimus-eluting stent was used in 44.8%, 
paclitaxel-eluting stent in 29%, and new-generation drug-eluting stent in 24.4%. During the follow-up period, TLF occurred in 488 (10.8%) patients. 
On survival analysis, TLF was not significantly different between 1-stent technique and 2-stent technique for non-left main bifurcation lesion (p = 
0.126). However, TLF for left main bifurcation lesions was significantly higher in 2-stent technique group (p = 0.003).
Conclusions: This study showed the overall trend for the treatment with drug-eluting stent of bifurcation lesions in Korea. We currently analyze this 
data in more detail and hope that they will be presented at ACC 2012.
